CAM
TRIL
Cormorant Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,500,000
| Closed | -$35.5M | – | 111 |
|
|
2020
Q3 | $35.5M | Buy |
+2,500,000
| New | +$35.5M | 1.37% | 22 |
|
|
2018
Q4 | – | Sell |
-500,000
| Closed | -$2.9M | – | 71 |
|
|
2018
Q3 | $2.9M | Sell |
500,000
-73,208
| -13% | -$425K | 0.19% | 54 |
|
|
2018
Q2 | $3.44M | Hold |
573,208
| – | – | 0.25% | 49 |
|
|
2018
Q1 | $4.13M | Sell |
573,208
-26,792
| -4% | -$193K | 0.31% | 40 |
|
|
2017
Q4 | $4.38M | Hold |
600,000
| – | – | 0.46% | 36 |
|
|
2017
Q3 | $3.09M | Hold |
600,000
| – | – | 0.55% | 41 |
|
|
2017
Q2 | $2.64M | Buy |
+600,000
| New | +$2.64M | 0.44% | 50 |
|